A-share Announcement Highlights | Enflame Technology (688801.SH): Cumulative deviation of three-day price decline exceeds 30%; unrestricted tradable shares account for only 4.16% of total share capital.

date
20:10 19/11/2026
avatar
GMT Eight
Enflame Technology (688801.SH) announced that the cumulative deviation of the company's stock closing price decline over three consecutive trading days from November 17 to 19 reached more than 30%, constituting an abnormal fluctuation in stock trading.
Today's Focus 1. Sanan Optoelectronics: All 26.30% of shares held by the controlling shareholder and indirect controlling shareholder are frozen; cumulative queued freezing reaches 166.81% of total share capital Sanan Optoelectronics (600703.SH) announced that 38.6949 million shares held by its indirect controlling shareholder Fujian Sanan Group have been subject to queued freezing by the Shanghai Financial Court, accounting for 21.22% of its holdings and 0.78% of the company's total share capital. The freezing arose from a financial leasing contract dispute between Xinxin Financial Leasing Group and Sanan Group and Rixin Photovoltaics. As of November 18, the controlling shareholder Xiamen Sanan Electronics and Sanan Group together held 1.312 billion shares, accounting for 26.30% of total share capital, all of which are under judicial freezing; after this queued freezing, the two shareholders have cumulatively had 8.322 billion shares queued-frozen, accounting for 634.17% of their holdings and 166.81% of the company's total share capital. The company said that the controlling shareholder remains independent from the company in assets, business, finance and other aspects, there is no non-operating occupation of funds, irregular guarantees or other circumstances harming the interests of the listed company, and the above freezing will temporarily not have a material impact on control rights or corporate governance; if not properly resolved later, there is a risk of affecting the stability of control rights. 2. CXMT Corporation: Repurchase amount adjusted to RMB2.5 billion to RMB5 billion, of which RMB1.5 billion to RMB3 billion is for safeguarding company value and will be cancelled CXMT Corporation (688825.SH) announced that the board reviewed and approved an adjustment to the repurchase plan, with total repurchase funds of no less than RMB2.5 billion and no more than RMB5 billion, a maximum price of RMB63.78 per share, and funds sourced from own or self-raised funds. Of this, RMB500 million to RMB1 billion each is for equity incentives or employee stock ownership plans and for cancellation and reduction of registered capital, while RMB1.5 billion to RMB3 billion is for safeguarding company value and shareholder rights and interests, and such shares will be cancelled after the repurchase is completed. The implementation period for the incentive and cancellation portions is within 12 months after approval by the shareholders' meeting and requires the company to have been listed for 6 months, while the value-safeguarding portion is within 3 months. The plan still requires review by the shareholders' meeting on December 9. As of the closing price of RMB40.41 per share on November 6, the cumulative decline over 20 consecutive trading days reached 20%, meeting the condition of being "necessary to safeguard company value and shareholder rights and interests." 3. Hygon Information Technology: First repurchase of 1,376,700 shares for RMB235 million Hygon Information Technology (688041.SH) announced that the company repurchased 1,376,700 shares for the first time through centralized bidding, accounting for 0.06% of total share capital, at a transaction price of RMB162.69 to RMB174.99 per share, with RMB235 million paid. The total repurchase plan is RMB500 million to RMB800 million, with a maximum price of RMB318.52 per share, funded by own or self-raised funds. The company has obtained a commitment from CITIC BANK Beijing Branch for a special repurchase loan of no more than RMB720 million. The company said that the current supply chain system is stable, market demand for CPU and DCU products continues to expand, and research and development of next-generation products is progressing steadily along the established route. 4. Enflame Technology: Three-day decline deviation exceeds 30% cumulatively; says orders on hand are abundant and tradable shares account for only 4.16% of total share capital Enflame Technology (688801.SH) announced that the cumulative deviation of the company's closing price decline over three consecutive trading days from November 17 to 19 reached more than 30%, constituting abnormal stock trading fluctuations. After self-examination and written inquiry to the actual controller, the company and the actual controller confirmed that there is no undisclosed material information that should be disclosed, including mergers and acquisitions, share issuance, asset injection and other matters. The company said it has noted that recent relevant industry news has attracted substantial attention, that orders on hand are currently abundant, and that it is cooperating with a number of domestic semiconductor industry partners to build cloud AI chip products based on a domestic supply chain. The company also cautioned that there are currently 17.9003 million unrestricted tradable shares, accounting for only 4.1595% of total share capital; the number of tradable shares is relatively small, and short-term stock price fluctuations are relatively large. 5. Nexchip Semiconductor Corporation: Signs capital increase agreement with Hefei Construction Investment and others; three parties together subscribe to new registered capital with RMB9.1 billion Nexchip Semiconductor Corporation (688249.SH) announced that the company, Hefei Construction Investment and Hefei Qinhe signed a capital increase agreement with the target company on November 19, under which the three parties together subscribed in cash RMB9.1 billion to the target company's new registered capital. The agreement was established after being signed and sealed by the legal representatives or authorized representatives of each party, and will take effect after the company's shareholders' meeting approves this capital increase; it still requires independent shareholders' approval. A circular containing details of the capital increase agreement, a letter from the independent board committee and the opinion of the independent financial adviser is expected to be published on or before December 31. 6. Cofoe Medical Technology: Acquires 60% equity of Kangjuren for RMB99.48 million; target will be consolidated Cofoe Medical Technology (301087.SZ) announced that the company signed an equity transfer agreement with Guo Bensheng, Guo Benli and Anhui Yangjingling Enterprise Management Consulting to acquire 60% equity of Hefei Kangjuren Medical Device Technology for RMB99.48 million using own funds. After the transaction is completed, Kangjuren will become a controlled subsidiary and be included in the consolidated financial statements. The transaction has been approved by the board and does not need to be submitted to the shareholders' meeting; it does not constitute a related-party transaction or a major asset restructuring. 7. YTO Express Group: October express product revenue RMB6.512 billion, up 4.76% year on year YTO Express Group (600233.SH) announced that in October 2026 express product revenue was RMB6.512 billion, up 4.76% year on year; business volume was 3.062 billion parcels, up 9.77% year on year; and revenue per express product parcel was RMB2.13, down 4.56% year on year. The above data are unaudited. Repurchases & Increases/Decreases in Holdings 1. Ganfeng Lithium Group: Plans to repurchase RMB200 million to RMB400 million, maximum price RMB57.47 per share Ganfeng Lithium Group (002460.SZ) announced that the repurchase is for safeguarding company value, and is expected to repurchase 0.17% to 0.33% of shares. 2. Biwin Storage Technology: Plans to repurchase RMB200 million to RMB250 million, all for cancellation and capital reduction Biwin Storage Technology (688525.SH) announced a maximum price of RMB269.47 per share; the plan has been approved by the shareholders' meeting. 3. Zhejiang Century Huatong Group: First repurchase of 3,603,100 shares for RMB38.8177 million Zhejiang Century Huatong Group (002602.SZ) announced a transaction price of RMB10.73 to RMB10.82 per share, with a total plan of RMB300 million to RMB600 million. 4. Jinke Property Group: Plans to repurchase RMB150 million to RMB300 million, maximum price RMB1.5 per share Jinke Property Group (000656.SZ) announced that the repurchase is for safeguarding company value; the closing decline over 20 trading days reached 21.62%. Major Contracts 1. CSPC Innovation Pharmaceutical: Receives US$15 million licensing milestone payment from Corbus CSPC Innovation Pharmaceutical (300765.SZ) announced that cumulative receipts for the CRB-701 project reached US$32.5 million, which will enhance performance. 2. CECEP Guozhen Environmental Protection Technology: Consortium wins RMB396 million No. 10 Water Plant project CECEP Guozhen Environmental Protection Technology (300388.SZ) announced that the company will undertake 30% of the project workload; a formal contracting agreement has not yet been signed. Other 1. Jiangsu Hengrui Pharmaceuticals: Class 1 innovative drug receives approval for a new indication; cumulative R&D investment RMB260 million Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that fosrolapitant palonosetron has received a new indication for the prevention of MEC-induced vomiting. 2. Quantumctek Co., Ltd.: Controlling shareholder and others commit not to reduce holdings before the end of 2027 Quantumctek Co., Ltd. (688027.SH) announced that the committing parties together hold 34.05%, including 21.86% held by China Telecom Quantum Group.